Volume 2008, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426


To assess the effect of an insulin pump on the glycemic control as well as the body mass index (BMI) of children with type 1 diabetes mellitus (DM1), 23 patients under the age of 18 years were monitored for one year or more. HbAlc concentration decreased from 9.36+/- 2.02% to 8.54+/-1.149%. The BMI increased significantly from 17.12+/- 2.236 to 20.4+1- 2.93. No hypoglycemia was reported in any of the patients after using the pump. Three incidences of diabetic-ketoacidosis (DKA) were reported due to two pump malfunctions and one patient error. All except two wanted to continue with the pump because of the desirable flexibility of their lifestyle including activity and meal times.


Article metrics loading...

Loading full text...

Full text loading...


  1. Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ i. 1978;:204207.
    [Google Scholar]
  2. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in Type 1 diabetes. Diabetes Care. 2002; 25::593598.
    [Google Scholar]
  3. Nogaard K. A nationwide study of continuous subcutaneous insulin infusion (CSII) in Denmark. Diabet Med. 2003; 20::307311.
    [Google Scholar]
  4. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Postgrad Med. 2002; 111::6977.
    [Google Scholar]
  5. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care. 2004; 27::S110.
    [Google Scholar]
  6. Wilson DM, Buckingham BA, Kunselman El, Sullivan MM. A two center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes care. 2005; 28::1519.
    [Google Scholar]
  7. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with Typel diabetes: A randomized open crossover trial. Pediatrics. 2003; 112::559564.
    [Google Scholar]
  8. Radermecker R, Pscheen AJ. Continuous subcutaneous insulin infusion with short acting insulin analogues or human regular insulin: Efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab. Res Rev;. 2004; 20::178188.
    [Google Scholar]
  9. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC. Diabetes management in the new mellinum using insulin pump therapy. Diabetes metab. Res Rev. 2002; 18:suppl.l:S1420.
    [Google Scholar]
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error